To investigate the pathways that PUS7 may be involved in or may regulate in ovarian cancer, a GSEA pathway analysis was performed using TCGA data, which was separated into a high (top 25%) PUS7 group and a low (down 75%) PUS7 group. This evidence concerns the gene PUS7 and ovarian carcinoma.